Do Inhaled B2-Agonists have an Ergogenic Potential in Non-Asthmatic Competitive Athletes?

@article{Kindermann2007DoIB,
  title={Do Inhaled B2-Agonists have an Ergogenic Potential in Non-Asthmatic Competitive Athletes?},
  author={W. Kindermann},
  journal={Sports Medicine},
  year={2007},
  volume={37},
  pages={95-102}
}
  • W. Kindermann
  • Published 2007
  • Medicine
  • Sports Medicine
  • AbstractThe prevalence of asthma is higher in elite athletes than in the general population. The risk of developing asthmatic symptoms is the highest in endurance athletes and swimmers. Astma seems particularly widespread in winter-sport athletes such as cross-country skiers. Asthmatic athletes commonly use inhaled β2-agonists to prevent and treat asthmatic symptoms. However, β2-agonists are prohibited according to the Prohibited List of the World Anti-Doping Agency. An exception can be made… CONTINUE READING

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    The overall objective for this study is to test whether β2-agonists will affect the cardiopulmonary capacity of VSD-operated patients compared with un-operated VSD-patients and… Expand
    ConditionsVentricular Septal Defect
    InterventionDrug
    Asthma in elite athletes
    11
    β2-Agonists and Physical Performance
    57
    The World Anti-Doping Code: can you have asthma and still be an elite athlete?
    9

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 76 REFERENCES